✦ LIBER ✦

Estramustine phosphate (Estracyt®) in the treatment of prostatic carcinoma

✍ Scribed by I. Könyves

Book ID: 110556067
Publisher: Springer Netherlands
Year: 1989
Tongue: English
Weight: 254 KB
Volume: 21
Category: Article
ISSN: 0301-1623
DOI: 10.1007/bf02559635

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of estramustine phosphate (Es

Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinoma

✍ S. B. Andersson; P. O. Gunnarsson; T. Nilsson; G. Plym Forshell 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 573 KB

Pharmacokinetics of estramustine phospha

Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patients

✍ P. O. Gunnarsson; S. -B. Andersson; S. -Å. Johansson; T. Nilsson; G. Plym-Forshe 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 732 KB

Monoclonal antibodies against the estram

Monoclonal antibodies against the estramustin-binding protein monotoring the treatment of prostatic carcinoma with estracyt

✍ F. Donn; A. Paasarge; W. Becker; T. Bruhns; H. Becker; H. Griesohn 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Treatment of Advanced Carcinoma of the P

Treatment of Advanced Carcinoma of the Prostate with Estramustine Phosphate

✍ R. NAGEL; C.-P. KÖLLN 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB

Estramustine Phosphate in the Treatment

Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer

✍ S. KHOURY; F. RICHARD; F. FOURCADE; P. FRANTZ; J. P. CAPELLE 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Estramustine phosphate (estracyt) follow

Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer

✍ Francesco Boccardo; Andrea Decensi; Domenico Guarneri; Giuseppe Martorana; Claud 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 331 KB

Twenty-two orchiectomized men with progressive stage D2 prostate cancer were treated with a 3-week cycle of estramustine phosphate (EMP: from day 3 to day 21) and androgen priming (from day 1 to day 4). A partial response according to the NPCP-USA criteria was shown in 4 of 20 evaluable patients. Me